Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Q -- HRSA 340B Prime Vendor Agreement

Active
HRSA-232-BPHC-AG-01(6)Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the extension of the HRSA 340B Prime Vendor Agreement for an additional year, from September 10, 2006, through September 9, 2007, under the exercise of Option Year One as outlined in Section VIII of the original agreement dated September 10, 2004. The prime vendor, Health Purchasing Partners International, has effectively served 340B safety-net hospitals and clinics by negotiating significant discounts on over 2200 brand and generic drugs, achieving prices between 1 and 77 percent below the statutory 340B ceiling price, averaging 10.9 percent below. In addition, the vendor secured agreements with 13 national and regional drug distributors, including specialty wholesalers tailored to smaller clinics, resulting in an average 7 percent reduction in distribution costs. Beyond drug pricing, the vendor has enhanced the value offered through negotiations for additional products and services such as vaccines, diabetic supplies, and rapid HIV test kits, supporting the diverse needs of the participating healthcare providers. The announcement clarifies that this is not a solicitation but an extension of the existing agreement. The contracting officer handling this agreement is Francis R Murphy, who can be contacted via email or phone. The contract is associated with NAICS code 446110, reflecting its relevance to retail pharmacies or drug stores.

General Info

Extension of HRSA 340B Prime Vendor Agreement, reducing drug and distribution costs for safety-net providers.

Agency

N/A

NAICS

446110 - Pharmacies and Drug Stores

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Francis R MurphyContracting Officer

Full Description

Show more
In accordance with the HRSA 340B Prime Vendor Agreement, Section VIII, Terms effective September 10, 2004, the Agreement will be extended, through the exercise of Option Year One, by one year (September 10, 2006 through September 9, 2007). HRSA's 340B Prime Vendor (PV), Health Purchasing Partners International, has brought significant value to participating 340B safety-net hospitals and clinics during the first two years of the five year agreement with HRSA by performing tasks under the agreement, such as, negotiating for over 2200 brand and generic drug prices at 1 to 77 percent below the statutory 340B ceiling price, with an average of 10.9 percent below ceiling; negotiating drug wholesale distributor agreements with 13 national and regional distributors, including specialty wholesalers to address the special needs of smaller clinics for an average 7 percent reduction in distribution costs; and negotiating "other value added products and services" that include such items as vaccines, diabetic meters and strips, and rapid HIV Test Kits. THIS ANNOUNCEMENT IS NOT A NOTICE OF SOLICITATION.

Similar Contracts

Same NAICS industry code

NAICS: 446110
Federal
Specialty Pharmacy Fulfillment of Lenalidomide (Revlimid)The contract involves the specialty pharmacy fulfillment and delivery of Lenalidomide (Revlimid), a medication used primarily in the treatment of certain cancers and blood disorders, to patients of the Department of Veterans Affairs (VA). The contractor is responsible for dispensing either branded or therapeutically equivalent versions of Lenalidomide in varying strengths. This service must comply with Risk Evaluation and Mitigation Strategies (REMS) protocols, ensuring safe and effective use of the medication. Essential contract activities include verifying prescriptions, conducting patient outreach to support medication adherence and understanding, securely packaging the medication, and ensuring delivery is confirmed by obtaining signatures upon receipt. This subcontract is issued by the 252-NETWORK Contract Office 12 under the Department of Veterans Affairs and aligns with NAICS code 446110, which typically covers pharmacies and drug stores. While specific performance location details and points of contact are not provided, the contract underscores the importance of compliance with federal safety standards and thorough patient management. The seamless coordination of prescription verification, patient communication, packaging, and secure delivery highlights the contractor’s critical role in supporting VA patients’ access to this specialized pharmaceutical therapy.
252-NETWORK Contract Office 12 (36C252)

POSTED

10 months ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS